Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 288

    1.

    Plasma HIV viral load in patients with hemophilia and late-stage HIV disease: a measure of current immune suppression. Multicenter Hemophilia Cohort Study.

    Engels EA, Rosenberg PS, O'Brien TR, Goedert JJ.

    Ann Intern Med. 1999 Aug 17;131(4):256-64.PMID: 10454946 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count.

    Vlahov D, Graham N, Hoover D, Flynn C, Bartlett JG, Margolick JB, Lyles CM, Nelson KE, Smith D, Holmberg S, Farzadegan H.

    JAMA. 1998 Jan 7;279(1):35-40.PMID: 9424041 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study.

    Yeo AE, Matsumoto A, Hisada M, Shih JW, Alter HJ, Goedert JJ.

    Ann Intern Med. 2000 Jun 20;132(12):959-63.PMID: 10858179 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.

    Mellors JW, Muñoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, Kingsley LA, Todd JA, Saah AJ, Detels R, Phair JP, Rinaldo CR Jr.

    Ann Intern Med. 1997 Jun 15;126(12):946-54.PMID: 9182471 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapy.

    MacArthur RD, Perez G, Walmsley S, Baxter JD, Mullin CM, Neaton JD; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) 042/045; Canadian HIV Trials Network (CTN) 102 Protocol Teams.

    HIV Clin Trials. 2005 May-Jun;6(3):127-35.PMID: 16192247 [PubMed - indexed for MEDLINE]Related articles

    6.

    AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

    Ledergerber B, Egger M, Erard V, Weber R, Hirschel B, Furrer H, Battegay M, Vernazza P, Bernasconi E, Opravil M, Kaufmann D, Sudre P, Francioli P, Telenti A.

    JAMA. 1999 Dec 15;282(23):2220-6.PMID: 10605973 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Evaluation of surrogate markers and clinical outcomes in two-year follow-up of eighty-six human immunodeficiency virus-infected pediatric patients.

    Valentine ME, Jackson CR, Vavro C, Wilfert CM, McClernon D, St Clair M, Katz SL, McKinney RE Jr.

    Pediatr Infect Dis J. 1998 Jan;17(1):18-23.PMID: 9469389 [PubMed - indexed for MEDLINE]Related articles

    8.

    Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children.

    Palumbo PE, Raskino C, Fiscus S, Pahwa S, Fowler MG, Spector SA, Englund JA, Baker CJ.

    JAMA. 1998 Mar 11;279(10):756-61.PMID: 9508151 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.

    García F, Romeu J, Grau I, Sambeat MA, Dalmau D, Knobel H, Gomez-Sirvent JL, Arrizabalaga J, Cruceta A, Clotet BG, Podzamczer D, Pumarola T, Gallart T, O'Brien WA, Miró JM, Gatell JM.

    AIDS. 1999 Dec 3;13(17):2377-88.PMID: 10597779 [PubMed - indexed for MEDLINE]Related articles

    10.

    Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.

    Ledergerber B, Lundgren JD, Walker AS, Sabin C, Justice A, Reiss P, Mussini C, Wit F, d'Arminio Monforte A, Weber R, Fusco G, Staszewski S, Law M, Hogg R, Lampe F, Gill MJ, Castelli F, Phillips AN; PLATO Collaboration.

    Lancet. 2004 Jul 3-9;364(9428):51-62.PMID: 15234856 [PubMed - indexed for MEDLINE]Related articles

    11.

    Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320.

    Demeter LM, Hughes MD, Coombs RW, Jackson JB, Grimes JM, Bosch RJ, Fiscus SA, Spector SA, Squires KE, Fischl MA, Hammer SM.

    Ann Intern Med. 2001 Dec 4;135(11):954-64.PMID: 11730396 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection. Multicenter AIDS Cohort Study.

    Saah AJ, Hoover DR, Weng S, Carrington M, Mellors J, Rinaldo CR Jr, Mann D, Apple R, Phair JP, Detels R, O'Brien S, Enger C, Johnson P, Kaslow RA.

    AIDS. 1998 Nov 12;12(16):2107-13.PMID: 9833851 [PubMed - indexed for MEDLINE]Related articles

    13.

    Joint effects of HIV-1 RNA levels and CD4 lymphocyte cells on the risk of specific opportunistic infections.

    Williams PL, Currier JS, Swindells S.

    AIDS. 1999 Jun 18;13(9):1035-44.PMID: 10397533 [PubMed - indexed for MEDLINE]Related articles

    14.

    The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of < or = 50 x 10(6) cells/l.

    Coakley EP, Samore MH, Gillis JM, Hughes MD, Hammer SM.

    AIDS. 2000 Jun 16;14(9):1147-53.PMID: 10894278 [PubMed - indexed for MEDLINE]Related articles

    15.

    Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.

    Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC.

    N Engl J Med. 2001 Mar 8;344(10):720-5.PMID: 11236775 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Course of viral load throughout HIV-1 infection.

    Sabin CA, Devereux H, Phillips AN, Hill A, Janossy G, Lee CA, Loveday C.

    J Acquir Immune Defic Syndr. 2000 Feb 1;23(2):172-7.PMID: 10737432 [PubMed - indexed for MEDLINE]Related articles

    17.

    Prognostic value of plasma HIV RNA in the natural history of Pneumocystis carinii pneumonia, cytomegalovirus and Mycobacterium avium complex. Multicenter AIDS Cohort Study.

    Lyles RH, Chu C, Mellors JW, Margolick JB, Detels R, Giorgi JV, Al-Shboul Q, Phair JP.

    AIDS. 1999 Feb 25;13(3):341-9.PMID: 10199224 [PubMed - indexed for MEDLINE]Related articles

    18.

    Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases.

    Daniel V, Süsal C, Weimer R, Zimmermann R, Huth-Kühne A, Opelz G.

    AIDS Res Hum Retroviruses. 2001 Mar 1;17(4):329-35.PMID: 11242519 [PubMed - indexed for MEDLINE]Related articles

    19.

    Immune markers and viral load after HIV-1 seroconversion as predictors of disease progression in a cohort of haemophilic men.

    Sabin CA, Devereux H, Phillips AN, Janossy G, Loveday C, Lee CA.

    AIDS. 1998 Jul 30;12(11):1347-52.PMID: 9708415 [PubMed - indexed for MEDLINE]Related articles

    20.

    HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.

    Phillips AN, Staszewski S, Weber R, Kirk O, Francioli P, Miller V, Vernazza P, Lundgren JD, Ledergerber B; Swiss HIV Cohort Study; Frakfurt HIV Clinic Cohort; EuroSIDA Study Group.

    JAMA. 2001 Nov 28;286(20):2560-7.PMID: 11722270 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data